Design, Synthesis, and Antisickling Investigation of a Nitric Oxide-Releasing Prodrug of 5HMF for the Treatment of Sickle Cell DiseaseRana T. Alhashimi, Martin K. Safo, Osheiza Abdulmalik et al.|Biomolecules|2022Cited by 7
Design, Synthesis, and Investigation of Novel Nitric Oxide (NO)-Releasing Aromatic Aldehydes as Drug Candidates for the Treatment of Sickle Cell DiseaseBoshi Huang, Martin K. Safo, Mohini S. Ghatge et al.|Molecules|2022Cited by 6
Potent Antisickling Furaldehyde Analogs for Acute Sickle Cell Therapy: Enhanced Efficacy and Intravenous Formulation PotentialAbdelsattar M. Omar, Martin K. Safo, Moustafa E. El‐Araby et al.|ChemMedChem|2025Cited by 1
A Novel Direct Hemoglobin S Polymerization Inhibitor for the Treatment of Sickle Cell Disease - <i>In Vivo</i> Efficacy of Ilx-002 in Humanized MiceOsheiza Abdulmalik, Andrew N. Fleischman, Kandace Gollomp et al.|Blood|2024Cited by 0
Hemoglobin: A Target for Sickle Cell Disease Drug DiscoveryAkua K. Donkor, Martin K. Safo, Albert Opare et al.|Unknown|2026Cited by 0